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Reply to Cunha et al
TO THE EDITOR—In a previous study,
Cunha et al showed that polymorphisms
in long pentraxin 3 (PTX3) inﬂuenced
susceptibility to invasive aspergillosis
among hematopoietic stem cell trans-
plant recipients [1]. A similar association
is now reported in 2 studies of solid organ
transplant recipients, the Swiss Trans-
plant Cohort Study [2], and a cohort of
lung transplant recipients, as described
in the current letter by Cunha et al [3].
The risk allele arises, respectively, from
the donor of hematopoietic stem cells
and from the recipient of solid organ
transplant, which is consistent with the
different origin of immune cells in these
patients. The functional role of PTX3 in
fungal immunity has been demonstrated
both in vitro and in vivo [4–6], and there
is evidence that the polymorphisms inﬂu-
ence the genes’ expression [1]. Altogether,
these observations make PTX3 polymor-
phisms a promising host genetic marker
of infection in transplant recipients.
Polymorphisms in >20 genes have been
reported to inﬂuence susceptibility to in-
vasive aspergillosis in oncohematological
patients [7]. After initial studies, the con-
cept rapidly emerged that aspergillosis
risk could be stratiﬁed according to a com-
bination of genetic and nongenetic factors,
and that patient management could be
personalized, for instance by using speciﬁc
surveillance and/or prophylactic regimens
in the higher-risk patients [8].Yet, such
strategies have not been implemented so
far. Some of the polymorphisms initially
associated with susceptibility to invasive
aspergillosis had low minor allele frequen-
cies [9, 10], thereby limiting the ability to
obtain replication, as very large conﬁrma-
tory cohorts would be needed to reach a
sufﬁcient statistical power. Other studies
were limited by methodological issues or
by a lack of a deﬁnite role for the reported
genes and/or polymorphism(s) in antifun-
gal immunity [7]. In addition, prophylac-
tic regimens have been used increasingly,
especially among hematopoietic stem cell
transplant recipients, making it more difﬁ-
cult to replicate associations observed
without prophylaxis.
Because the association of PTX3 poly-
morphisms seems robust, it might be
considered as a key factor for risk stratiﬁ-
cation. Yet, many questions remain open,
such as in which population it would be
most beneﬁcial, and to which extent it
would impact individual management.
Thoracic organ recipients may constitute
a potential group for further studies, be-
cause those patients have a relatively high
risk to develop the infection and they do
not routinely receive antifungal prophy-
laxis inmany centers. Yet, due to the small
number of patients studied so far, the
number of variables that can be imple-
mented together within a potential score
is limited, and makes it difﬁcult to esti-
mate risk and beneﬁt. Large novel pro-
spective studies or meta-analysis from
several studies using systematically select-
ed markers would be needed to address
these questions before formal recommen-
dations can be made.
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